Resistance or susceptibility to disseminated and mucosal Candida albicans infections in mice correlates with the development of protective or nonprotective T helper (Th) cell responses. To determine whether immunomodulatory activity on Th cell functions is an effect beyond that provided by antifungal therapy, mice with disseminated or gastrointestinal infection were treated with amphotericin B or fluconazole and assessed for mortality, fungus burden in the organs, and parameters of Th cell -dependent immunity. Both antimycotics produced protective CD4 / Th1 cell responses, as revealed by increased production of interleukin (IL)-12 and interferon-g, decreased production of IL-4, delayed-type hypersensitivity to fungal antigen, and the disappearance of antigen-specific IgE. Concomitant neutralization of endogenous IL-4 greatly increased the antifungal efficacy and the Th1-promoting activity of both agents. These results indicate that successful antifungal therapy alone or in combination with cytokine antagonists may rely on the induction of an appropriate Th antifungal cell response. The effects of cytokines on Th cell responses in vivo were found to be so dependent on the timing of cytokine appearance of these infections.
Deep-seated candidal infections are important causes of in-
Th cell subset development and regulation in murine candidiasis [14] . Among these are cytokines, which act as modulators fectious morbidity and mortality in immunocompromised patients [1, 2] . Several classes of antifungal compounds, including of antifungal effector functions and as key regulators in the development of the different Th cell subsets from precursor triazoles, echinocandins, and amphotericin B liposomal formulations, are being developed for management of invasive candiTh cells. Thus, neutralization of interferon-g (IFN-g) [15] , transforming growth factor-b [16] , or interleukin (IL)- 12 [17] diasis [3 -5] . Nevertheless, the mortality associated with systemic Candida albicans infection is ú50% [6] . Several factors and administration of IL-4 or IL-10 [18] early in infection led to the onset of Th2 responses; administration of transforming restrict the use and efficacy of the available antifungal agents [7] , including their decreased efficacy in eradicating systemic growth factor-b [16] and endogenous IL-4 [19, 20] or IL-10
[21] neutralization resulted in the onset of Th1 responses. infections in severely immunocompromised hosts [8 -10] . Hence, alternative strategies would be useful for the treatment
The effects of cytokines on Th cell responses in vivo were found to be so dependent on the timing of cytokine appearance of these infections.
Recent studies have increased our understanding of the imthat factors affecting the type and timing of cytokine appearance profoundly influenced the induction and expression of Th munopathology of fungal infections [11] , thus offering opportunities for immunobased therapeutic strategies. It has been functions in mice with candidiasis [22] . One such factor is represented by the dose of C. albicans administered. Low levels demonstrated that T helper (Th) cells play a central role in regulating immune responses to C. albicans by secreting cytoof infection caused mice, which normally experience severe disease and mount a dominant Th2 response, to mount a Th1 kines that modulate the development and activity of immune effectors. The outcome of systemic and mucosal C. albicans response [14, 22] , a finding similar to that obtained in murine leishmaniasis [23] . Therefore, regulation of the initial fungus infections in mice was found to be largely dependent upon which of the two major CD4 / Th cell subsets predominates: burden may affect Th subset differentiation, as clearly evidenced in neutrophil-depleted, normally resistant mice mountTh1 cell development leads to resistance and onset of protective immunity, whereas Th2 cell responses are associated with susing a Th2 rather than a Th1 cell response to a given dose of C. albicans [14] . ceptibility to candidal diseases [12, 13] . Many factors control Because amphotericin B and fluconazole possess potent anticandidal activity in vivo and in vitro [24] and because amphotericin B increases host resistance in C. albicans -in-JID 1997;176 (July) amphotericin B 24 h after inoculation or daily ig doses (20 infection were treated with either a 10 mg/kg ip dose of amphoteriFemale mice, 2-4 weeks old, were used. The mutant mouse strain cin B 7 days before or 24 h after inoculation or with a 2 mg/kg 129/Sv/Ev, which is deficient in expression of the a chain of the ig dose of fluconazole on days 1-14 after infection. Doses, routes IFN-g receptor (IFN-g R 0 / 0 ) [26] , and wild-type strain 129/Sv/ of administration, and treatment schedules were selected on the Ev, which is not deficient in expression of the a chain of the basis of our previous experience [25] for amphotericin B and by IFN-g receptor (IFN-g R / / / ), were a gift of Manfred Kopf (Basel reference to published work for fluconazole [30] . Control mice Institute for Immunology, Basel, Switzerland).
received vehicle alone. Antifungal agents. Amphotericin B (Fungizone) was purCombination therapy with sIL-4R. Treatment with sIL-4R chased from Bristol-Myers Squibb (Sermoneta, Italy). A standard (Behringwerke, Marburg/Lahn, Germany) was done as described solution of the drug was prepared by dissolving 50 mg of ampho- [20, 22] . In the disseminated infection group, mice were treated tericin B with 41 mg of sodium deoxycholate in 10 mL of distilled ip with 0.1 mg/kg amphotericin B 7 days before iv challenge and water. Further dilutions were made with a 5% glucose-water soluthen injected ip with sIL-4R (10 mg/injection) on the day of and tion. Fluconazole was supplied by Bioindustria Farmaceutici (Novi 1, 2, and 3 days after infection. In the gastrointestinal infection Ligure, Italy); it was provided in a 50-mL nonpyrogenic water group, mice were treated daily from day 1 to 14 after challenge solution containing 100 mg of fluconazole and 450 mg of sodium with 2 mg/kg fluconazole ig and with sIL-4R ip (10 mg/injection) chloride. Further dilutions were made in PBS.
on the day of and 1, 2, 3, and 5 days after infection.
Yeast, infections and enumeration of colony-forming units (cfu).
Purification and culture of CD4 / T cells. CD4 / lymphocytes The C. albicans strain used in this study was isolated from a were positively selected from pools of spleen cells by means of a clinical specimen and identified as described previously [25] . The panning procedure using purified anti-murine CD4 monoclonal yeast was grown at 28ЊC under slight agitation in low-glucose antibody (MAb) GK1. Cytokine assays. IFN-g and IL-4 levels were determined in the 24-h culture, cells were harvested by low-speed centrifugation supernatants by means of a cytokine-specific ELISA, using pairs (1000 g), washed twice in saline, and diluted to the desired density of anti-cytokine MAbs, as previously described [16, [19] [20] [21] . For for intravenous (iv) injection (0.5-mL volume/mouse) via the latserum IL-12p70 measurement, a modified antibody-capture bioaseral tail vein. The viability of the cells was ú95% by trypan blue say was used as described [16] . [19] [20] [21] . The assay involved cells delivered via an 18-gauge, 4-cm-long plastic catheter, as coating the microtiter plate wells with Candida antigen, adding described [20, 27, 28] . Yeast cells in organs of infected mice appropriate dilutions of test antisera, and reacting further with (6-8 per group) were quantitated by a plate-dilution method, using biotinylated rat anti-mouse IgE MAb (Sanbio Biological Products, Sabouraud dextrose agar, and results (mean { SE) were expressed Uden, Netherlands) and an avidin-alkaline phosphatase conjugate. as cfu per organ.
After addition of the substrate solution, the optical density of tripliDisseminated candidiasis model. Mice were infected iv with cate samples was read with an ELISA reader, using a 405-nm 2 1 10 5 C. albicans blastoconidia, an inoculum size that results filter. in a median survival time of 12-17 days for infected mice, as
Delayed-type hypersensitivity (DTH) assay. The direct assay indicated by pilot experiments. Treatments with antifungal agents system for measuring the DTH response to cell surface antigens were as follows.
was used [15, [19] [20] [21] . Whole heat-inactivated C. albicans cells Preventive treatment. Various doses (10, 1, or 0.1 mg/kg) of (2 1 10 6 ) were inoculated into the footpads of C. albicans-infected amphotericin B were given intraperitoneally (ip) to mice on day mice in a volume of 40 mL. The DTH reaction was recorded 24 7 before the infectious challenge. For fluconazole, 20 mg/kg was h later by weighing the footpads as a measure of swelling, and given ig daily for 7 days before infection.
the results were expressed as the increase in footpad weight over Early treatment. Eight normal mice per experiment were left that of the saline-injected counterpart. Data were expressed as the untreated; the rest were randomly separated into treatment groups (8/group) and given either one ip dose (10, 1, or 0.1 mg/kg) of means { SEs of 6 mice per group. JID 1997;176 (July) Combination Therapy in Murine Candidiasis
RNA preparation and reverse transcriptase (RT)-polymerase
When survivors were assessed for resistance to reinfection, chain reaction (PCR). Macrophages (obtained by 2-h plastic adthey were found to be partially (10 mg/kg dose) or completely herence, ú95% pure on esterase staining) from pooled spleens of (1 mg/kg) resistant. Early treatment (24 h after infection) with 3 to 4 animals were subjected to RNA extraction by the guanidium any of the doses of amphotericin B resulted in cure of mice thiocyanate-phenol-chloroform procedure as previously defrom the primary infection. However, only mice treated with scribed [31] . In brief, 3 mg of total RNA was incubated with 0.5 the higher doses showed increased resistance to reinfection. mg of oligo(dT) (Pharmacia, Uppsala, Sweden) for 3 min at 65ЊC
Preventive To correlate these findings with fungal growth in the organs, mL. cDNA was diluted to a total volume of 500 mL with TE buffer fungus cells were quantitated in the kidneys of infected mice was evident in mice treated with 10 mg/kg of amphotericin B
Synthesized cDNA from each sample was amplified as described either before or after infection. A persistent and significant previously [32] . In brief, 5 mL of cDNA was added to a reaction reduction of fungal growth was observed after preventive or mixture containing 50 mM KCl, 10 mM TRIS-HCl (pH 8. early treatment with 20 mg/kg significantly inhibited fungal Each 100-mL sample was overlaid with 75 mL of mineral oil growth in the organs at both 1 and 2 weeks after infection. At (Sigma, St. Louis) and incubated in a DNA Thermal Cycler 480 (Perkin-Elmer) for a total of 30 cycles for each cytokine. For b-2 mg/kg, significant inhibition was observed only at 1 week;
actin and IL-12, the cycles and temperatures were as described no significant effects on fungal growth were observed when [33] . The b-actin primers were used as a control for RT and for fluconazole (20 mg/kg) was given before infection (data not the PCR reaction itself and also for comparing the amount of shown). respectively [12 -14] , parameters of specific CD4 / Th cell immunity were examined in iv infected mice given antifungal more than 85% survived primary infection, a result in line with previous findings [25] .
treatment. To this purpose, IFN-g (Th1) and IL-4 (Th2) cyto-/ 9d2b$$jy03 05-27-97 15:37:45 jinfas UC: J Infect kine production by CD4 / cells, serum levels of Candida-spe-CD4 / T cells were purified from spleens of infected and treated mice at 1 and 2 weeks after infection. Cells were antigencific IgE, and development of DTH reactivity were assessed in mice given curative treatment (i.e., 1 mg/kg amphotericin stimulated in vitro before assessment of IFN-g and IL-4 production in the culture supernatants. B 7 days before infection or 20 mg/kg fluconazole daily on days 1 -14 after infection) or noncurative treatment (i.e., 0.1 As shown in figure 3 , IL-4 production increased and IFN-g production decreased in infected, nontreated mice over the mg/kg amphotericin B or 2 mg/kg fluconazole given as above). course of the infection. The same pattern of cytokine produckidneys (data not shown). None of these effects were observed in IFN-g R 0 / 0 mice. Therefore, these data suggest that in the tion was observed in mice exposed to noncurative treatment with fluconazole (2 mg/kg), although the actual cytokine proabsence of a direct activity of the drug on fungal cells, the curative effect of amphotericin B greatly relies on its ability to duction was lower. For amphotericin B -treated mice, IFN-g production increased over the course of infection; however, the induce Th1 protective responses through an IFN-g -dependent mechanism. increase was not paralleled by a decrease in IL-4 production. In contrast, curative treatment with fluconazole (20 mg/kg) or
Effect of concomitant treatment with sIL-4R on the efficacy amphotericin B (1 mg/kg) resulted in dramatically impaired
of amphotericin B and fluconazole. We have already shown IL-4 production and improved IFN-g production, particularly that neutralization of endogenous IL-4 results in cure of mice at 2 weeks after infection. These results were paralleled by an from either disseminated [19] or gastrointestinal [20] infection. increased frequency of cells producing IFN-g and a decrease
To determine whether concomitant neutralization of endogeof those producing IL-4 in the spleens of mice at 2 weeks after nously produced IL-4 could increase the efficacy of amphoteriinfection (data not shown). Therefore, treatment with amphocin B and fluconazole, mice with disseminated or gastrointestitericin B or fluconazole appears to alter the ratio between Th1 nal infection were treated with a suboptimal dose of sIL-4R and Th2 cytokine -producing cells in C. albicans -infected and noncurative doses of amphotericin B (one 0.1 mg/kg dose mice.
7 days before infection) or fluconazole (daily 2 mg/kg injecTo further document the effect of antifungal agents on Th tions on days 1 -14 after challenge). Mice were monitored for cell subset development, serum levels of antigen-specific IgE fungal growth in the organs. The results (figure 5) show that and development of DTH reactivity were assessed 2 weeks each treatment alone was effective, although transiently, in after infection in mice given curative doses of fluconazole.
reducing fungal growth in vivo. However, combined treatment Figure 4 shows that IgE serum levels were greatly reduced in (antifungal plus sIL-4R) greatly increased the efficacy of both mice as a consequence of treatment; conversely, a strong DTH drugs, as revealed by a higher and persistent inhibition of fungal reactivity appeared in treated mice, and a weak reactivity apgrowth in the kidneys and stomach of infected mice. Thus, peared in vehicle-injected mice (controls). These results indicate that the curative effect of the antifungal agents is associated with the occurrence of predominant anticandidal CD4 wild-type mice ( combined treatment with sIL-4R and either agent resulted in a offered opportunities to manipulate these processes and to alter the outcome of antimicrobial host responses [34, 35] . The failsynergistic anticandidal effect.
To assess whether combined treatment also resulted in a ure to control or resolve infections is often the result of inappropriate rather than insufficient immune responses. In fungal inmodified pattern of cytokine production, serum levels of bioactive IL-12 and IL-12p40 gene expression in splenic macrofections, activation of the different types of Th cell subsets has been well documented [12] . phages were evaluated. Bioactive IL-12 levels were greatly increased in the serum of mice given amphotericin B or fluco-
In the present study, we provide evidence that curative treatments with amphotericin B or fluconazole were associated with nazole combined with sIL-4R (figure 6). Similarly, combined treatments greatly increased the expression of IL-12p40 gene the occurrence of IFN-g -dependent Th1 cell responses in mice with disseminated candidiasis. Mice cured from the primary expression in macrophages. Because IL-12 is both prognostic and required for Th1 development in mice with candidiasis infection acquired resistance to reinfection (table 1) , and this correlated with the detection of increased production of [17], these results further indicate that the ability of amphotericin B and fluconazole to promote anticandidal Th1 cell devel-IFN-g, but not IL-4, by CD4 / T cells from spleens ( figure 3 ). IgE serum levels, which are often increased in human systemic opment is greatly potentiated by the concomitant inhibition of endogenous IL-4.
fungal infections [36] , decreased in cured mice. In contrast, strong DTH reactivity appeared (figure 4), thus confirming the important role of cell-mediated immunity in candidiasis Discussion [37 -40] . Increased levels of circulating IL-12p70 were observed in mice with disseminated ( figure 6 ) or gastrointestinal The appreciation of the importance of T cell function in the overall coordination of the immune response to pathogens has (data not shown) infections, thus indicating the occurrence of [45, 46] . In an experimental model of C. albicans infection, the therapeutic activity of amphotericin B greatly relied on its ability to activate antifungal effector functions of macrophages [25] . In humans, amphotericin B improved the clinical outcome of patients with documented systemic candidiasis even though serum levels were well below the MIC for the infecting pathogen [47] . In accord, the results of the present study show the high efficacy of a single administration of amphotericin B against yeast challenge 7 days after treatment, at a time when the drug concentration in plasma is barely detectable [25] .
Unlike amphotericin B, fluconazole was not found to have immunostimulatory properties [41, 48, 49] . However, the notion that fluconazole is not effective against intracellular C. albicans [50] poses the question as to whether the efficacy of fluconazole also relies on an active immune system. Prelimi- An interesting observation of the present study is that mice kg daily on days 1 -14 after infection; sIL4R, 10 mg/dose on day of and 1, 2, and 3 days after challenge. At 2 weeks after infection, ILexposed to early treatment with the highest doses of amphoteri12p70 was determined by means of antibody-capture assay, and ILcin B, although able to survive the primary infection, failed to 12p40 gene expression was determined in splenic macrophages by mount long-lasting resistance to reinfection. We have already means of reverse transcriptase -polymerase chain reaction (PCR). ILshown that for durable anticandidal protection to occur, a per12p70 serum levels from uninfected naive mice were below detection sistent, albeit low, antigenic fungus load appears to be required limit of assay (indicated by õ in y axis). C Å b-actin or cytokinespecific controls; N Å no DNA added to amplification mix during [22] . Therefore, it is likely that the potent antifungal activity PCR. exerted by amphotericin B in these conditions may result in a rapid clearance of fungus cells, thus preventing the retention of durable anticandidal immunologic memory.
These results indicate that either amphotericin B or fluconaprotective Th1 responses in both types of infections. For amphotericin B, induction of protection was not observed in mice zole may exhibit immunomodulatory functions on antifungal Th cell responses, an activity that appears to depend on both functionally deficient in IFN-g (table 2), thus indicating the importance of this cytokine in the immunomodulatory activity the time and dose of drug administration. Whatever the mechanism by which amphotericin B and fluof the drug.
Recent studies demonstrated that the initial fungus burden conazole induce anticandidal protective Th1 responses, this activity was potentiated by concomitant treatment with the may affect Th subset differentiation in mice with candidiasis [14, 22] . Here we show that induction of Th1 responses corre-IL-4 antagonist, sIL-4R. We showed that a dose of amphotericin B or fluconazole, ineffective in altering the course of dislates with a low fungus burden in the organs (figures 2 and 3), thus providing further evidence for the importance of the ease, could significantly reduce the fungus load in the organs when administered with sIL-4R ( figure 5 ). As shown in figure antigenic load in Th cell selection [14, 22] .
Anaissie et al. [24] showed a positive correlation between 3, either drug alone, at the doses used, induced only quantitative but not qualitative changes in the pattern of cytokine production the anticandidal activity in vitro of amphotericin B and fluconazole and their ability to prolong survival and reduce tissue by CD4 / splenocytes, thus evidencing the failure to induce Th1 cell development. However, combination treatment with counts in infected mice. Thus, the direct interaction of either drug with C. albicans could be a major mechanism leading to either drug and sIL4R resulted in the increased production of IL-12 ( figure 6 ), an indicator of the occurrence of Th1 reTh1 selection in mice with candidiasis. However, the results of our study do not exclude the possibility of an interaction of sponses [17] . These results indicate that concomitant IL-4 neu-
